NCT04908423 - Xeomin® and Gait Related Mobility After Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Stroke

Interventions

DRUG

Xeomin®

To discover whether injection into the upper extremity with Xeomin® triggers improvements in gait-related mobility and quality of life in adults with hemiparesis secondary to stroke.

Trial Locations (1)

28203

RECRUITING

Carolinas Rehabilitation, Charlotte